251 related articles for article (PubMed ID: 10700932)
1. Monitoring the effects of preventive therapy in the Federated States of Micronesia.
Cho SN; Walsh GP; Brennan PJ
Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4 Suppl):S19-22. PubMed ID: 10700932
[No Abstract] [Full Text] [Related]
2. Mycobacterium leprae particle agglutination in diagnosis and monitoring of treatment of leprosy.
Kampirapap K
J Med Assoc Thai; 1999 Oct; 82(10):1020-4. PubMed ID: 10561966
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence rates of antibodies to phenolic glycolipid-I among school children as an indicator of leprosy endemicity.
van Beers S; Hatta M; Klatser PR
Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):243-9. PubMed ID: 10575403
[TBL] [Abstract][Full Text] [Related]
4. Effects of chemotherapy on antibody levels directed against PGL-I and 85A and 85B protein antigens in lepromatous patients.
Drowart A; Chanteau S; Huygen K; De Cock M; Cartel JL; De Bruyn J; Launois P; Yernault JC; Van Vooren JP
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):29-34. PubMed ID: 8326178
[TBL] [Abstract][Full Text] [Related]
5. Bangkok Workshop on Leprosy Research. Immunodiagnostics, including skin tests.
Brennan PJ; Cho SN; Klatser PR
Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4 Suppl):S58-62. PubMed ID: 9030127
[No Abstract] [Full Text] [Related]
6. Serological monitoring of the response to chemotherapy in leprosy patients.
Roche PW; Britton WJ; Failbus SS; Neupane KD; Theuvenet WJ
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):35-43. PubMed ID: 8326179
[TBL] [Abstract][Full Text] [Related]
7. Implementation of chemoprophylaxis in Pohnpei State, Federated States of Micronesia.
Iehsi-Keller E
Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4 Suppl):S14-5. PubMed ID: 10700930
[No Abstract] [Full Text] [Related]
8. Antibodies to phenolic glycolipid-I during long-term therapy: serial measurements in individual patients.
Miller RA; Gorder D; Harnisch JP
Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4):633-6. PubMed ID: 3323367
[TBL] [Abstract][Full Text] [Related]
9. Quantitative relationship between anti-PGL-I-specific antibody levels and the lepromin reaction.
David HL; Maroja M F; Cruaud P
Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):332-4. PubMed ID: 2071994
[No Abstract] [Full Text] [Related]
10. A comparative and combinatorial study on two serological assays for detection of Mycobacterium leprae infection.
Parkash O; Girdhar BK
Acta Leprol; 2001-2002; 12(2):63-9. PubMed ID: 12136738
[TBL] [Abstract][Full Text] [Related]
11. Leprosy. An update: definition, pathogenesis, classification, diagnosis, and treatment.
Eichelmann K; González González SE; Salas-Alanis JC; Ocampo-Candiani J
Actas Dermosifiliogr; 2013 Sep; 104(7):554-63. PubMed ID: 23870850
[TBL] [Abstract][Full Text] [Related]
12. Serodiagnosis of infection with Mycobacterium leprae.
Buchanan TM; Young DB; Miller RA; Khanolkar SR
Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):524-30. PubMed ID: 6200450
[No Abstract] [Full Text] [Related]
13. The contribution of serological tests to leprosy control.
Klatser PR; Cho SN; Brennan PJ
Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4 Suppl):S63-6; discussion S66-7. PubMed ID: 9030128
[No Abstract] [Full Text] [Related]
14. [Serological diagnosis of leprosy].
Klatser PR; Naafs B; Faber WR
Ned Tijdschr Geneeskd; 1991 May; 135(21):932-4. PubMed ID: 2052109
[No Abstract] [Full Text] [Related]
15. Implementation of chemoprophylaxis in Chuuk State, Federated States of Micronesia.
Takashima J
Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4 Suppl):S16-8. PubMed ID: 10700931
[No Abstract] [Full Text] [Related]
16. Active surveillance of leprosy contacts in country with low prevalence rate.
Kai M; Maeda Y; Maeda S; Fukutomi Y; Kobayashi K; Kashiwabara Y; Makino M; Abbasi MA; Khan MZ; Shah PA
Int J Lepr Other Mycobact Dis; 2004 Mar; 72(1):50-3. PubMed ID: 15217314
[TBL] [Abstract][Full Text] [Related]
17. A study on the reproducibility of two serological assays for detection of Mycobacterium leprae infection.
Parkash O
Int J Lepr Other Mycobact Dis; 2001 Mar; 69(1):46-8. PubMed ID: 11480319
[No Abstract] [Full Text] [Related]
18. Bangkok Workshop on Leprosy Research. Research needs related to epidemiology and control: subclinical infection.
Gupte MD
Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4 Suppl):S29-36; discussion S36-7. PubMed ID: 9030121
[No Abstract] [Full Text] [Related]
19. Association between leprosy reactions after treatment and bacterial load evaluated using anti PGL-I serology and bacilloscopy.
Brito Mde F; Ximenes RA; Gallo ME; Bührer-Sékula S
Rev Soc Bras Med Trop; 2008; 41 Suppl 2():67-72. PubMed ID: 19618079
[TBL] [Abstract][Full Text] [Related]
20. Long-term evaluation of immune status in leprosy patients undergoing multiple drug therapy.
Vu TT; Hoang TL; Nguyen DQ; Ho ML; Nguyen DH; Le TH; Dang DT; Nguyen QA; Le TP; Tran HK
Int J Lepr Other Mycobact Dis; 1994 Sep; 62(3):365-73. PubMed ID: 7963908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
